The Patent Finder

Adicet Bio, Inc.

4 patents currently held · Updated Nov 21, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded as renamed to Adicet Therapeutics, Inc. (2022)

0
Ending by 2030
Nov 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 4 of 4

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,371,663Engineered γδ T-cells
In force
 · USPTO record
In forceUSPTO record
US 11,001,642Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same
In force
 · USPTO record
In forceUSPTO record
US 11,485,785Antibodies capable of binding HLA-A2/TyrD in an HLA restricted manner and uses thereof
In force
 · USPTO record
In forceUSPTO record
US 12,252,547Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same
In force
 · USPTO record
In forceUSPTO record
Also on record, not counted in the 4: 4 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 1 no status recorded

Showing 1 to 3 of 3, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
17/782,129Methods for Expanding Gamma Delta T-Cell Populations with Multivalent Agents and Compositions ThereofDec 3, 2020Pending
17/298,903Methods for Selective in Vivo Expansion of Gamma Delta T-Cell Populations and Compositions ThereofDec 3, 2019Pending
15/579,974Jun 8, 2016No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited